MedTrace Logo

Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy

NCT04120818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2019-10-09

No results posted yet for this study

Summary

In this prospective study , a cohort of 58 eyes with congenital cataract from Wenzhou medical university was erolled.33 eyes with congenital cataract was after lensectomy and anterior vitrectomy as post-surger group, 26 eyes without cataract surgery as control group. The cytokines of MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15 was evaluated

Conditions

  • Congenital Cataract

Interventions

PROCEDURE

secondary IOL implantation

reopened the fibrotic, closed capsular bag and achieve IOL placement

PROCEDURE

primary IOL implantation

lensectomy and anterior vitrectomy and primary IOL implantation

Sponsors & Collaborators

  • yin ying zhao

    lead OTHER

Eligibility

Min Age
10 Months
Max Age
72 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-04
Primary Completion
2017-02-12
Completion
2017-02-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04120818 on ClinicalTrials.gov